For older women, behavioral therapy (BT) reduces overactive bladder (OAB) symptoms, with greater improvements seen in ...

Christina Escobar, MD, MHPE, Assistant Professor in the Departments of Urology and Obstetrics and Gynecology at NYU Grossman School of Medicine, discusses, among other issues, how telehealth has ...

Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, ...

DEAR DR. ROACH: In two weeks, I am supposed to get Botox injections in my bladder for an overactive bladder (OAB) and my frequent need to urinate at nighttime. Are these injections safe? Are there any ...

(Reuters) - The popular Botox wrinkle treatment made by Allergan Inc has been approved to treat adults with overactive bladder who cannot tolerate or failed to be helped by other drugs for the ...

Overactive bladder and urinary incontinence can disrupt daily life and even keep you from enjoying exercise. Treatments like ...

DEAR DR. ROACH: I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive bladder. I need to urinate at least every two hours. Often ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending vibegron (Obgemsa, Pierre Fabre) for treating overactive bladder (OAB) syndrome in adults. The ...

DEAR DR. ROACH: In two weeks, I am supposed to get Botox injections in my bladder for an overactive bladder (OAB) and my frequent need to urinate at nighttime. Are these injections safe? Are there any ...

Add Yahoo as a preferred source to see more of our stories on Google. Aiello lost all bladder control and function, so she had her bladder rerouted to her belly button where she inserts a catheter to ...

Gemtesa (vibegron) and Myrbetriq (mirabegron) are prescription drugs used to treat overactive bladder. Gemtesa comes as an oral tablet, and Myrbetriq comes as both extended-release oral tablets and ...

Active ingredient: Fesoterodine fumarate 4 mg, 8 mg; extended-release tablets. Indication: Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency. Pharmacology: Fesoterodine ...